Covered recipient · General Payments record
KAWANTA F DURHAM
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,698.23
- Reported across 114 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $425.43 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $157.13 | 13 |
| Novo Nordisk AS | $144.64 | 13 |
| Abbott Laboratories | $70.81 | 3 |
| ABBVIE INC. | $39.07 | 2 |
| Xeris Pharmaceuticals, Inc. | $13.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.24 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125289802 | CMS |
| Abbott Laboratories | $25.39 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125289804 | CMS |
| Abbott Laboratories | $23.18 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125289806 | CMS |
| ABBVIE INC. | $20.56 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103669802 | CMS |
| ABBVIE INC. | $18.51 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103669804 | CMS |
| Lilly USA, LLC | $6.36 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135102481 | CMS |
| Lilly USA, LLC | $16.66 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135112896 | CMS |
| Lilly USA, LLC | $19.15 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135076971 | CMS |
| Lilly USA, LLC | $20.59 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135102483 | CMS |
| Lilly USA, LLC | $16.90 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135125158 | CMS |
| Lilly USA, LLC | $15.04 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135123379 | CMS |
| Lilly USA, LLC | $6.65 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135076973 | CMS |
| Lilly USA, LLC | $0.23 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135076975 | CMS |
| Lilly USA, LLC | $6.66 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135112898 | CMS |
| Lilly USA, LLC | $10.51 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135100370 | CMS |
| Lilly USA, LLC | $4.61 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135123381 | CMS |
| Lilly USA, LLC | $20.81 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135126164 | CMS |
| Lilly USA, LLC | $12.96 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135125160 | CMS |
| Novo Nordisk Inc | $8.42 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096875200 | CMS |
| Novo Nordisk Inc | $3.08 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096712964 | CMS |
| Novo Nordisk Inc | $15.77 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096904699 | CMS |
| Novo Nordisk Inc | $10.78 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096629221 | CMS |
| Novo Nordisk Inc | $19.93 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097099962 | CMS |
| Novo Nordisk Inc | $7.68 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096679256 | CMS |
| Novo Nordisk Inc | $10.79 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096720884 | CMS |
| Novo Nordisk Inc | $13.47 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096800086 | CMS |
| Novo Nordisk Inc | $16.12 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097564568 | CMS |
| Novo Nordisk Inc | $5.76 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097310747 | CMS |
| Novo Nordisk Inc | $18.49 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096868792 | CMS |
| Novo Nordisk Inc | $8.50 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097443343 | CMS |
| Novo Nordisk Inc | $5.85 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097251530 | CMS |
| Xeris Pharmaceuticals, Inc. | $13.78 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144601301 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.